Opinion - Public or private? That's the story of the "first draft" of the human genome

What's behind today's announcement of the first draft of the genome.

Written byRobert Walgate
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The man from CNN was puzzled. Dr Jane Rogers, project manager of human sequencing at the Sanger Centre, the UK's human genome laboratory, had just told the eager press and TV at a news conference at the Wellcome Trust, London, this morning (26 June) that the Human Genome Project had now covered 97% of the genome.

But only 87% was sequenced. And only 24% had reached the "gold standard" of 99.99% accuracy. And two or three more years' work will be needed to fill gaps in the 28 000 clones and reach the desired overall accuracy.

"So why didn't you wait until you'd finished?" asked the TV man.

The somewhat lame answer was that "we always said there'd be a draft by 2000". So said Michael Dexter, Director of the Wellcome Trust - which has spent £210 million on the UK effort - amounting to roughly one-third of the human ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA